Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000295724 | SCV000366460 | benign | Focal segmental glomerulosclerosis 2 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV001546367 | SCV001765870 | likely benign | not provided | 2020-02-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294261 | SCV002587455 | likely benign | Kidney disorder | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001546367 | SCV005214057 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001701997 | SCV001932648 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701997 | SCV001959892 | benign | not specified | no assertion criteria provided | clinical testing |